Fn-ta-pfc/pck scaffold

1 paper2 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funders: Fundamental Research Funds for the Central Universities and 3 more

Animals1

Outcomes

Angiogenesis

upin mice1

1 study

Fn-ta-pfc/pck scaffold increases angiogenesis in mice.
“Further evaluation in calvarial defect models of aged mice, ovariectomized (OVX) rats, and SD rats demonstrated the scaffold's robust angiogenic and osteogenic activity.”
Animalscalvarial defect models
Fiber scaffolds augment aged bone regeneration by modulating energy metabolism, immunity and angiogenesis
Journal of controlled release : official journal of the Controlled Release Society8 Nov 2025

Latest

1 in 12 months

Journal of Controlled Release11 Nov

Fiber scaffolds augment aged bone regeneration by modulating energy metabolism, immunity and angiogenesis

Experiments in miceBones and joints

Paper

Fn-ta-pfc/pck scaffold

Outcomes

Latest

Fiber scaffolds augment aged bone regeneration by modulating energy metabolism, immunity and angiogenesis

Related